Clinical trials
Completed Coronary Artery Disease trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Meshalkin Research Institute of Pathology of Circulation | 6 |
| I.M. Sechenov First Moscow State Medical University | 4 |
| AstraZeneca | 3 |
| Bayer | 3 |
| Servier Russia | 3 |
| Tomsk National Research Medical Center of the Russian Academy of Sciences | 3 |
| Gilead Sciences | 2 |
| Northern State Medical University | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Resverlogix Corp | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 48 |
| Myocardial Ischemia | 10 |
| Angina Pectoris | 5 |
| Atherosclerosis | 5 |
| Cardiovascular Diseases | 5 |
| Coronary Disease | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Heart Diseases | 5 |
| Myocardial Infarction | 5 |
| Coronary Stenosis | 4 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.